meRfi®-GM
The Digital Textbook on Gut Microbiota and Beyond
Cetuximab + Cisplatin + Fluorouracil (5-FU) & Head & Neck squamous cell carcinoma (HNSCC)
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
References (Sources)
- Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial
- Effect of adding motolimod to standard combination chemotherapy and cetuximab treatment of pts with HNSCC: the Active8 randomized clinical trial.
- Immunology and Immunotherapy of Head and Neck CancerReview
- Optimizing treatments for recurrent or metastatic head and neck squamous cell carcinoma
- Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study